Usmani, Omar
Roche, Nicolas
Wahab, Ezanul
Israel, Samuel
Jenkins, Martin
Trivedi, Roopa
Dorinsky, Paul
Aurivillius, Magnus
Funding for this research was provided by:
AstraZeneca
Article History
Received: 24 March 2021
Accepted: 28 July 2021
First Online: 7 October 2021
Declarations
:
: Participants completed an informed consent form, approved by the Independent Ethics Committee and sponsor before study initiation. This study was performed in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with International Council for Harmonization/Good Clinical Practice, applicable regulatory requirements.
: Not applicable.
: OU reports academic grants from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline; and personal fees from Aerocrine, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Mundipharma, NAPP, Prosonix Ltd, Sandoz, Takeda, and Zentiva NR reports grants and personal fees from Boehringer Ingelheim, Novartis, and Pfizer; and personal fees from AstraZeneca, Chiesi, Cipla, GlaxoSmithKline, Mundipharma, Sanofi, Teva, Trudell, and Zambon. EW and SI declare that they have no competing interests. MJ, RT, PD, and MA are employees of, and hold stock and/or stock options in, AstraZeneca.